Processes and barriers to implementation of point-of-care genotype-guided dosing of warfarin into UK outpatient anticoagulation clinics. (2019)

First Author: Fitzgerald G

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2217/pgs-2019-0021

PubMed Identifier: 31046595

Publication URI: http://europepmc.org/abstract/MED/31046595

Type: Journal Article/Review

Volume: 20

Parent Publication: Pharmacogenomics

Issue: 8

ISSN: 1462-2416